The Novo Nordisk-iDexis case was the conclusion of a dispute over the pharmacys use and marketing of semaglutide
If you experience symptoms that feel concerning or unexpected, seek medical guidance promptly from a qualified healthcare provider
Figure 1 GSTP Inhibits Nuclear-Cytoplasmic Translocation of HMGB1 and Release from Macrophages To investigate the effect of GSTP on release of HMGB1 from macrophages, we performed in vitro experiments on cultured primary cells and cell lines
If the provider has questions or needs additional information, they'll reach out
The results showed that tirzepatide led to greater reductions in HbA1c levels, fasting serum glucose, and body weight compared to placebo or a selective GLP-1 receptor agonist
New discoveries lead to better treatments, which generate new clinical questions and send us back to the laboratory